Lab-tested, ≥99.5% purity research compounds with a certificate of analysis behind every vial — for researchers 21 and older.
Peptara supplies research compounds for laboratory use only. Please confirm you are 21 or older to enter — you’ll create an account or sign in next.
ExitBy entering you confirm these materials are for laboratory research only — not for human consumption. Create an account anytime from My Account.
A dual GIP / GLP-1 receptor agonist studied for appetite regulation, glucose control and body-weight research.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — one of the most-studied incretin compounds in current metabolic research, investigated for appetite regulation, glucose control and body-weight outcomes.
Primary research applications
Tirzepatide activates both the GIP and GLP-1 incretin receptors. In research models it slows gastric emptying, enhances glucose-dependent insulin secretion, and acts on hypothalamic appetite centres to reduce food intake.
Research titration commonly begins low (e.g. 2.5 mg once weekly) and is increased gradually every four weeks as tolerated; slow titration limits GI effects in models.
This information is educational and is not medical advice. These compounds are sold for laboratory research use only and are not for human consumption. Do not begin any protocol without the supervision of a licensed healthcare provider.
Orders ship same or next business day via cold-chain courier from the USA. Free shipping over $200. Every shipment is lyophilised, sealed, and includes the lot's certificate of analysis.
Because these are research materials, opened vials are non-returnable. Damaged or incorrect orders are replaced at no charge — contact us within 7 days.